- Home
- SHFS vs LSTA Comparison
SHFS vs LSTA Comparison
Compare SHFS & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHFS
- LSTA
- Stock Information
- Founded
- SHFS 2015
- LSTA 1980
- Country
- SHFS United States
- LSTA United States
- Employees
- SHFS N/A
- LSTA N/A
- Industry
- SHFS Finance: Consumer Services
- LSTA Misc Health and Biotechnology Services
- Sector
- SHFS Finance
- LSTA Health Care
- Exchange
- SHFS Nasdaq
- LSTA Nasdaq
- Market Cap
- SHFS 20.8M
- LSTA 20.0M
- IPO Year
- SHFS N/A
- LSTA N/A
- Fundamental
- Price
- SHFS $3.14
- LSTA $2.07
- Analyst Decision
- SHFS
- LSTA Strong Buy
- Analyst Count
- SHFS 0
- LSTA 1
- Target Price
- SHFS N/A
- LSTA $15.00
- AVG Volume (30 Days)
- SHFS 11.9K
- LSTA 9.1K
- Earning Date
- SHFS 05-12-2025
- LSTA 05-08-2025
- Dividend Yield
- SHFS N/A
- LSTA N/A
- EPS Growth
- SHFS N/A
- LSTA N/A
- EPS
- SHFS N/A
- LSTA N/A
- Revenue
- SHFS $16,102,301.00
- LSTA $1,000,000.00
- Revenue This Year
- SHFS N/A
- LSTA N/A
- Revenue Next Year
- SHFS N/A
- LSTA N/A
- P/E Ratio
- SHFS N/A
- LSTA N/A
- Revenue Growth
- SHFS N/A
- LSTA N/A
- 52 Week Low
- SHFS $2.86
- LSTA $2.05
- 52 Week High
- SHFS $18.80
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- SHFS 24.30
- LSTA 34.86
- Support Level
- SHFS $4.25
- LSTA $2.31
- Resistance Level
- SHFS $6.68
- LSTA $2.46
- Average True Range (ATR)
- SHFS 0.63
- LSTA 0.15
- MACD
- SHFS -0.13
- LSTA -0.01
- Stochastic Oscillator
- SHFS 7.33
- LSTA 0.00
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.